These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 19858071)
21. A comprehensive contribution of genetic variations of the insulin-like growth factor 1 signalling pathway to stroke susceptibility. Yao Y; Zhu H; Zhu L; Fang Z; Fan Y; Liu C; Tian Y; Chen Y; Tang W; Ren Z; Li J; Yang S; Chen Y; Zhao X; Shen C Atherosclerosis; 2020 Mar; 296():59-65. PubMed ID: 32065979 [TBL] [Abstract][Full Text] [Related]
22. Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses. Murphy N; Carreras-Torres R; Song M; Chan AT; Martin RM; Papadimitriou N; Dimou N; Tsilidis KK; Banbury B; Bradbury KE; Besevic J; Rinaldi S; Riboli E; Cross AJ; Travis RC; Agnoli C; Albanes D; Berndt SI; Bézieau S; Bishop DT; Brenner H; Buchanan DD; Onland-Moret NC; Burnett-Hartman A; Campbell PT; Casey G; Castellví-Bel S; Chang-Claude J; Chirlaque MD; de la Chapelle A; English D; Figueiredo JC; Gallinger SJ; Giles GG; Gruber SB; Gsur A; Hampe J; Hampel H; Harrison TA; Hoffmeister M; Hsu L; Huang WY; Huyghe JR; Jenkins MA; Keku TO; Kühn T; Kweon SS; Le Marchand L; Li CI; Li L; Lindblom A; Martín V; Milne RL; Moreno V; Newcomb PA; Offit K; Ogino S; Ose J; Perduca V; Phipps AI; Platz EA; Potter JD; Qu C; Rennert G; Sakoda LC; Schafmayer C; Schoen RE; Slattery ML; Tangen CM; Ulrich CM; van Duijnhoven FJB; Van Guelpen B; Visvanathan K; Vodicka P; Vodickova L; Vymetalkova V; Wang H; White E; Wolk A; Woods MO; Wu AH; Zheng W; Peters U; Gunter MJ Gastroenterology; 2020 Apr; 158(5):1300-1312.e20. PubMed ID: 31884074 [TBL] [Abstract][Full Text] [Related]
23. Common genetic variation in the IGF1 associates with maximal force output. Huuskonen A; Lappalainen J; Oksala N; Santtila M; Häkkinen K; Kyröläinen H; Atalay M Med Sci Sports Exerc; 2011 Dec; 43(12):2368-74. PubMed ID: 21552154 [TBL] [Abstract][Full Text] [Related]
24. Association of Doria PLS; Moscovitz T; Tcherniakovsky M; Fernandes CE; Pompei LM; Wajman M; Nimwegen AV; Haimovich S Biomed Res Int; 2018; 2018():8704346. PubMed ID: 30643822 [TBL] [Abstract][Full Text] [Related]
25. Association between endometriosis and polymorphisms in insulin-like growth factor binding protein genes in Korean women. Kim H; Ku SY; Kim SH; Choi YM; Kim JG Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):96-101. PubMed ID: 22381038 [TBL] [Abstract][Full Text] [Related]
26. IGF1 and its binding proteins 3 and 1 are differentially associated with metabolic syndrome in older men. Yeap BB; Chubb SA; Ho KK; Setoh JW; McCaul KA; Norman PE; Jamrozik K; Flicker L Eur J Endocrinol; 2010 Feb; 162(2):249-57. PubMed ID: 19917654 [TBL] [Abstract][Full Text] [Related]
27. Association of IGF1 gene haplotypes with high myopia in Chinese adults. Mak JY; Yap MK; Fung WY; Ng PW; Yip SP Arch Ophthalmol; 2012 Feb; 130(2):209-16. PubMed ID: 22332214 [TBL] [Abstract][Full Text] [Related]
28. Comprehensive evaluation of genetic variation in the IGF1 gene and risk of prostate cancer. Johansson M; McKay JD; Stattin P; Canzian F; Boillot C; Wiklund F; Adami HO; Bälter K; Grönberg H; Kaaks R Int J Cancer; 2007 Feb; 120(3):539-42. PubMed ID: 17096324 [TBL] [Abstract][Full Text] [Related]
29. Higher IGFBP3 is associated with increased incidence of colorectal cancer in older men independently of IGF1. Chan YX; Alfonso H; Paul Chubb SA; Ho KKY; Gerard Fegan P; Hankey GJ; Golledge J; Flicker L; Yeap BB Clin Endocrinol (Oxf); 2018 Feb; 88(2):333-340. PubMed ID: 29044573 [TBL] [Abstract][Full Text] [Related]
30. Associations of IGF1 and IGFBPs 1 and 3 with all-cause and cardiovascular mortality in older men: the Health In Men Study. Yeap BB; Chubb SA; McCaul KA; Ho KK; Hankey GJ; Norman PE; Flicker L Eur J Endocrinol; 2011 May; 164(5):715-23. PubMed ID: 21378090 [TBL] [Abstract][Full Text] [Related]
31. IGF-I and IGFBP-3 polymorphisms in relation to circulating levels among African American and Caucasian women. D'Aloisio AA; Schroeder JC; North KE; Poole C; West SL; Travlos GS; Baird DD Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):954-66. PubMed ID: 19240240 [TBL] [Abstract][Full Text] [Related]
32. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. ; Key TJ; Appleby PN; Reeves GK; Roddam AW Lancet Oncol; 2010 Jun; 11(6):530-42. PubMed ID: 20472501 [TBL] [Abstract][Full Text] [Related]
33. Influence of polymorphisms in genes encoding for insulin-like growth factor (IGF)-I, insulin, and IGF-binding protein (IGFBP)-3 on IGF-I, IGF-II, and IGFBP-3 levels in umbilical cord plasma. Landmann E; Kollerits B; Kreuder JG; Blum WF; Kronenberg F; Rudloff S Horm Res Paediatr; 2012; 77(6):341-50. PubMed ID: 22739332 [TBL] [Abstract][Full Text] [Related]
34. Genetic variation in IGF1, IGFBP3, IRS1, IRS2 and risk of breast cancer in women living in Southwestern United States. Slattery ML; Sweeney C; Wolff R; Herrick J; Baumgartner K; Giuliano A; Byers T Breast Cancer Res Treat; 2007 Aug; 104(2):197-209. PubMed ID: 17051426 [TBL] [Abstract][Full Text] [Related]
35. Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies. Chen W; Wang S; Tian T; Bai J; Hu Z; Xu Y; Dong J; Chen F; Wang X; Shen H Eur J Hum Genet; 2009 Dec; 17(12):1668-75. PubMed ID: 19491931 [TBL] [Abstract][Full Text] [Related]
37. Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease. Su X; Colditz GA; Willett WC; Collins LC; Schnitt SJ; Connolly JL; Pollak MN; Rosner B; Tamimi RM Int J Cancer; 2010 Jan; 126(1):180-90. PubMed ID: 19551864 [TBL] [Abstract][Full Text] [Related]
38. Insulin-like Growth Factor-1, Insulin-like Growth Factor Binding Protein-3 and the Incidence of Malignant Neoplasms in a Nested Case-Control Study. Adachi Y; Nojima M; Mori M; Himori R; Kubo T; Yamano HO; Lin Y; Wakai K; Tamakoshi A; Cancer Prev Res (Phila); 2020 Apr; 13(4):385-394. PubMed ID: 31996369 [TBL] [Abstract][Full Text] [Related]
39. Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer. Gu F; Schumacher FR; Canzian F; Allen NE; Albanes D; Berg CD; Berndt SI; Boeing H; Bueno-de-Mesquita HB; Buring JE; Chabbert-Buffet N; Chanock SJ; Clavel-Chapelon F; Dumeaux V; Gaziano JM; Giovannucci EL; Haiman CA; Hankinson SE; Hayes RB; Henderson BE; Hunter DJ; Hoover RN; Johansson M; Key TJ; Khaw KT; Kolonel LN; Lagiou P; Lee IM; LeMarchand L; Lund E; Ma J; Onland-Moret NC; Overvad K; Rodriguez L; Sacerdote C; Sánchez MJ; Stampfer MJ; Stattin P; Stram DO; Thomas G; Thun MJ; Tjønneland A; Trichopoulos D; Tumino R; Virtamo J; Weinstein SJ; Willett WC; Yeager M; Zhang SM; Kaaks R; Riboli E; Ziegler RG; Kraft P Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2877-87. PubMed ID: 20810604 [TBL] [Abstract][Full Text] [Related]
40. Insulin-like growth factor-related components and the risk of liver cancer in a nested case-control study. Adachi Y; Nojima M; Mori M; Matsunaga Y; Akutsu N; Sasaki S; Endo T; Kurozawa Y; Wakai K; Tamakoshi A; Tumour Biol; 2016 Nov; 37(11):15125-15132. PubMed ID: 27662841 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]